Hemorheology, plasma protein composition and von Willebrand Factor in type I diabetic nephropathy

被引:0
|
作者
Zimmermann, J
Schramm, L
Wanner, C
Mulzer, E
Henrich, HA
Langer, R
Heidbreder, E
机构
[1] UNIV WURZBURG,DEPT MED,D-97080 WURZBURG,GERMANY
[2] UNIV WURZBURG,DEPT SURG,D-97080 WURZBURG,GERMANY
[3] UNIV WURZBURG,DIV EXPT SURG,D-97080 WURZBURG,GERMANY
关键词
nephropathy; hemorheology; blood viscosity; plasma viscosity; erythrocyte aggregation; erythrocyte deformability; fibrinogen; von Willebrand Factor;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Patients with IDDM, especially those with albuminuria are at high risk for macrovascular and microvascular complications. Besides the major classic risk factors altered hemorheology may also play a role. Plasma viscosity, erythrocyte aggregation and erythrocyte deformability are the major determinants of blood flow in the microcirculation. Therefore, these hemorheological parameters and plasma protein composition were evaluated in 58 IDDM-patients with none (N0), incipient (N1: albuminuria 30-300 mg/day) and overt clinical nephropathy (N2: albuminuria >300 mg/day). As an estimate of endothelial injury plasma levels of von Willebrand Factor (vWF) were investigated. Patients with incipient and clinical nephropathy exhibited increasing blood levels of fibrinogen (N0=2.47+/-0.09, N1=2.71+/-0.15, N2=3.49+/-0.24 g/l, p <0.001), alpha(2)-macroglobulin (N0=257+/-11, N1=251+/-21, N2=382+/-43 mg/100 ml, p <0.01) and haptoglobin (N0=174+/-16, N1=216+/-39, N2=278+/-36 mg/100 ml, p <0.05), whereas serum albumin concentration decreased (N0=5.1+/-0.1, N1=4.7+/-0.1, N2=4.1+/-0.2 g/100 ml, p <0.001). In the same patients erythrocyte aggregation (N0=10.0+/-0.4, N1=12.1+/-0.5, N2=12.9+/-0.6, p <0.001), plasma viscosity (N0=1.34+/-0.01, N1=1.38+/-0.02, N2=1.40+/-0.02 mPas, p <0.05) and erythrocyte rigidity (N0=0.05+/-0.01, N1=0.15+/-0.05, N2=0.09+/-0.02, p <0.05) were increased, predominantly in those with overt clinical nephropathy. Erythrocyte aggregation was positively correlated with plasma concentrations of fibrinogen (r=0.65, p <0.001) and alpha(2)-macroglobulin (r=0.35, p <0.05), but negatively with plasma albumin concentration (r=-0.49, p <0.001). Plasma viscosity was positively correlated with plasma concentrations of fibrinogen (r=0.46, p <0.001) and haptoglobin (r=0.46, p <0.001). Von Willebrand Factor levels were higher in patients with overt clinical nephropathy (N0=126+/-8, N1=136+/-12, N2=163+/-14%, p <0.09, P-N0-N2 <0.05). A significant correlation between vWF and the rheological determinants could not be detected. These data demonstrate that blood rheology is profoundly altered in patients with IDDM and nephropathy. Elevated levels of vWF may indicate endothelial damage, and changes in plasma viscosity as well as erythrocyte aggregability seem to be the result of altered plasma protein composition due to proteinuria. These abnormalities in hemorheology may be an aggravating factor promoting microvascular and macrovascular damage in patients with type I diabetes mellitus and nephropathy.
引用
收藏
页码:230 / 236
页数:7
相关论文
共 50 条
  • [1] Relationships between von Willebrand factor and hemorheology in sportsmen
    Melnikov, AA
    Vikulov, AD
    Bagrakova, SV
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2003, 29 (01) : 19 - 24
  • [2] The impact of von Willebrand factor on fibrin formation and structure unveiled with type 3 von Willebrand disease plasma
    Martinez-Vargas, Marina
    Courson, Justin
    Gardea, Luis
    Sen, Mehmet
    Yee, Andrew
    Rumbaut, Rolando
    Cruz, Miguel A.
    BLOOD COAGULATION & FIBRINOLYSIS, 2024, 35 (05) : 256 - 264
  • [3] Relationships between hemorheology, erythrocyte metabolism, and von Willebrand factor in athletes and patients with peripheral arterial disease
    Osetrov I.A.
    Vikulov A.D.
    Baranov A.A.
    Bagrakova S.V.
    Mel'nikov A.A.
    Human Physiology, 2006, 32 (6) : 701 - 706
  • [4] Von Willebrand factor abnormalities in IgA nephropathy
    Bertaglia, G
    Ossi, E
    Casonato, A
    Miglietta, A
    Forino, M
    Baggio, B
    Gambaro, G
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (03) : 474 - 479
  • [5] Von Willebrand factor in diabetic angiopathy
    Kessler, L
    Wiesel, ML
    Attali, P
    Mossard, JM
    Cazenave, JP
    Pinget, M
    DIABETES & METABOLISM, 1998, 24 (04): : 327 - 336
  • [6] Defect of heparin binding in plasma and recombinant von Willebrand factor with type 2 von Willebrand disease mutations
    Rastegar-Lari, G
    Ajzenberg, N
    Ribba, AS
    Vereycken-Holler, V
    Legendre, P
    Villoutreix, BO
    Meyer, D
    Baruch, D
    THROMBOSIS AND HAEMOSTASIS, 2001, 86 (06) : 1459 - 1465
  • [7] von Willebrand factor alloantibodies in type 3 von Willebrand disease
    Kotnik, Barbara Faganel
    Strandberg, Karin
    Debeljak, Marusa
    Kitanovski, Lidija
    Jazbec, Janez
    Benedik-Dolnicar, Majda
    Bakija, Alenka Trampus
    BLOOD COAGULATION & FIBRINOLYSIS, 2020, 31 (01) : 77 - 79
  • [8] Elevation of von Willebrand factor in plasma in diabetic patients with neuropathic foot ulceration
    Aso, Y
    Fujiwara, Y
    Tayama, K
    Inukai, T
    Takemura, Y
    DIABETIC MEDICINE, 2002, 19 (01) : 19 - 26
  • [9] Prognostic implications of retinopathy and a high plasma von Willebrand factor concentration in type 2 diabetic subjects with microalbuminuria
    Jager, A
    van Hinsbergh, VWM
    Kostense, PJ
    Emeis, JJ
    Nijpels, G
    Dekker, JM
    Heine, RJ
    Bouter, LM
    Stehouwer, CDS
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (03) : 529 - 536
  • [10] Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease
    Rydz, N.
    Grabell, J.
    Lillicrap, D.
    James, P. D.
    HAEMOPHILIA, 2015, 21 (05) : 636 - 641